{"url_path":"/sec/sprb/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-221605-index.html","accession_number":"0001193125-26-221605","cik":"0001683553","ticker":"SPRB","issuer_name":"SPRUCE BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1683553/0001193125-26-221605-index.html","primary_entity_key":"0001683553","primary_entity_name":"SPRUCE BIOSCIENCES, INC."},"word_count":51,"has_tables":true,"body_markdown":"Item 5. Other Information\n\nDuring the three months ended March 31, 2026, no director or Section 16 officer of the Company adopted, modified or terminated any \"Rule 10b5-1 trading arrangement\" or any \"non-Rule 10b5-1 trading arrangement,\" as each term is defined in Item 408(a) of Regulation S-K.\n\n73\n\n[Table of Contents](#table_contents)"}